Additively manufactured titanium test specimens
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring additively manufactured titanium test specimens to support ongoing research characterizing variability in additively manufactured devices, with estimated solicitation release on June 1, 2027 and award on July 1, 2027. The procurement is set aside for unrestricted competition.
The estimated award value ranges from $10,000 to $25,000. Interested vendors should contact the FDA's acquisition mailbox at cdhracquisitions@fda.hhs.gov for additional details.
Forecast text
Variability of additively manufactured devices has been identified as a key area of research through stakeholder engagement exercises. Several research projects are ongoing to investigate and characterize the variability of additively manufactured devices. Additively manufactured titanium specimens are needed to complete this research.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast